395 filings
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
6-K
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
S-8
SPRC
SciSparc Ltd
1 Apr 24
Registration of securities for employees
5:11pm
20-F
2023 FY
SPRC
SciSparc Ltd
Annual report (foreign)
1 Apr 24
5:03pm
6-K
SPRC
SciSparc Ltd
27 Mar 24
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
9:18am
6-K
ty0sphn76hw61m9f5dc8
15 Mar 24
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
8:00am
6-K
5q8p5nw1kjsq
13 Mar 24
Report of Foreign Private Issuer
9:06am
6-K
yxv1pylktz1
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
EFFECT
8kc kyowt
7 Mar 24
Notice of effectiveness
12:15am
SC 13G
ra5q1
6 Mar 24
SciSparc / YA II PN ownership change
5:02pm
6-K
i94p3g9g2v8yr39p
29 Feb 24
Report of Foreign Private Issuer
9:07am
F-1
j1eo8csfjq3 05y9
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
3s1bhdoo bate
27 Feb 24
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
8:35am
6-K
egmtyxt3w7 ivby
20 Feb 24
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
4:27pm
6-K
mszd6
12 Feb 24
Report of Foreign Private Issuer
4:27pm
6-K
0i3id7xy5o2sz
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm
6-K
jrfs69l3 82m1n
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
os6mlvk9j 46d
22 Jan 24
SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million
6:02am
UPLOAD
7oqiy0xb4
18 Jan 24
Letter from SEC
12:00am
CORRESP
8xj n9zccfgh4hbnna
5 Jan 24
Correspondence with SEC
12:00am